Posticy
Boost your SEO with Backlinks that are worth it
SR Ranko
Turn scattered startup information into focused action.
SR Booster
Submit your startup to 120+ top directories.
  • Last Ranking Update: 9 hours ago
  • Company

Company Rank

15,469

Country Rank

SR Score

37,939

SR Web

39,718

SR Social

4,141

KalVista Pharmaceuticals is an ophthalmology company focused on developing drugs for the treatment of diabetic macular edema (DME).

Acquired by Merck & Co., Inc. on October 10, 2017

Website: https://www.kalvista.com

Founded: January 01, 2011

Social:

 SR Traffic - Month

 Ahrefs

X

KalVista Pharmaceuticals Competitors

Add Competitor

Startup Industry Description
Diabetic & Me
Healthcare Equipment & Services Read about the lives of diabetics. - Read about the lives of diabetics, find diabetic f ...
MedManage
Healthcare Equipment & Services Daily Medication Log and Calendar - MedManage is a medication history, and calendar lo ...
MDacne
Healthcare Equipment & Services Treating Acne Was never this Easy - MDAlgorithms developed a Mobile App platform to di ...
View more competitors»

KalVista Pharmaceuticals Funding

Add Funding

Date Round Amount Investors
Jul 22, 2015 Series B $ 33,000,000
Aug 23, 2011 Series A £ 8,000,000

KalVista Pharmaceuticals Acquisitions

Add Acquisition

Date Acquired Amount
Jun 15, 2016
Carbylan Therapeutics
Undisclosed amount

KalVista Pharmaceuticals Products

Add Product

Product Stage Description
There are no products.

KalVista Pharmaceuticals Team

Add Team Member

Person Role Period
Andrew Crockett
Founder Unknown to Unknown
Edward P. Feener
Founder Unknown to Unknown
Lloyd P. Aiello
Founder Unknown to Unknown
View more team members»

KalVista Pharmaceuticals News

Add News

Date Title
There are no news.

KalVista Pharmaceuticals Statistics

Last Week

Rank

SR Score

Likes

Followers



Last Month

Rank

SR Score

Likes

Followers